{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-190531","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2022-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.689518+00:00","generated_at":"2026-06-24T18:17:29.820559+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aileron Therapeutics CMO Vojislav Vukovic departs; severance agreement reached","bullets":["Chief Medical Officer Vojislav Vukovic, M.D., Ph.D. separated from Aileron on July 8, 2022.","Separation was not due to any disagreement with the company regarding operations, policies, or practices.","Severance includes nine months of semi-monthly salary continuation and COBRA premium payments.","Separation agreement contains customary release of claims, non-solicit, non-disparagement, and cooperation covenants.","No successor or interim CMO has been announced as of the filing date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-190531","json":"https://secwatch.observer/filing/0001193125-22-190531.json","markdown":"https://secwatch.observer/filing/0001193125-22-190531.md","text":"https://secwatch.observer/filing/0001193125-22-190531.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312522190531/0001193125-22-190531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312522190531/d367608d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T18:17:29.820559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3524c99172","claim":"Vojislav Vukovic departed as Chief Medical Officer at Rein Therapeutics, Inc..","evidence_excerpt":"On July 8, 2022, Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a Separation and Release of Claims Agreement with Vojislav Vukovic, M.D., Ph.D. (the “Separation Agreement”), which provides for Dr. Vukovic’s separation of employment as Senior Vice President, Chief Medical Officer of the Company, effective July 8, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312522190531/0001193125-22-190531-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}